Jaspreet Grewal's guest appearances

Jaspreet Grewal

The Cannabis Conversation | Medical Cannabis | CBD | Hemp

Jason Mitchell

Catherine Wilson

Matt Brown

Nick Davis

Colin Morgan

Neil Mahapatra

Chris Kelly

Bruce Linton

Steve DeAngelo

Chris Walsh

Alan Brochstein

Montel Williams

Vanmala Subramaniam

Bonni Goldstein

George Kruis

OwlTail

Mitchell Osak

Steve Hajioff

This week, we’re joined by Jaspreet Grewal, Mitchell Osak, &amp; Steve Hajioff - three subject matter specialists within the psychedelics space.In this special panel episode, we explore the emergence (and re-emergence) of therapeutic psychedelics, including examining the substances which have gained early traction, the investment case for them, and the challenges and opportunities of this new sector. 📚 VIEW SHOW NOTES AND EXTRAS:https://www.canverse.global/shownotes/e158Quotables[Psilocybin] can't be viewed as a miracle drug for everybody. I think that's really what it comes down to. We have to be very pragmatic that it's still an investigational compound. - JaspreetResourcesConnect with Steve on Linkedin: https://www.linkedin.com/in/stevehajioff/?originalSubdomain=ukConnect with Jaspreet on Linkedin: https://www.linkedin.com/in/jkgrewal/Connect with Mitchell on Linkedin:  https://www.linkedin.com/in/mitchellosak/

This week, we’re joined by Jaspreet Grewal, Mitchell Osak, &amp; Steve Hajioff - three subject matter specialists within the psychedelics space.In this special panel episode, we explore the emergence (and re-emergence) of therapeutic psychedelics, including examining the substances which have gained early traction, the investment case for them, and the challenges and opportunities of this new sector. 📚 VIEW SHOW NOTES AND EXTRAS: <a href="https://www.canverse.global/shownotes/e156" rel="nofollow" target="_blank">https://www.canverse.global/shownotes/e158</a> Quotables[Psilocybin] can't be viewed as a miracle drug for everybody. I think that's really what it comes down to. We have to be very pragmatic that it's still an investigational compound. - Jaspreet ResourcesConnect with Steve on Linkedin: <a href="https://www.linkedin.com/in/stevehajioff/?originalSubdomain=uk" rel="nofollow" target="_blank">https://www.linkedin.com/in/stevehajioff/?originalSubdomain=uk</a>Connect with Jaspreet on Linkedin: <a href="https://www.linkedin.com/in/jkgrewal/" rel="nofollow" target="_blank">https://www.linkedin.com/in/jkgrewal/</a>Connect with Mitchell on Linkedin:  <a href="https://www.linkedin.com/in/mitchellosak/" rel="nofollow" target="_blank">https://www.linkedin.com/in/mitchellosak/</a>

EPISODE #158 Psychedelics: The Investment Case with Jaspreet Grewal, Mitchell Osak, & Steve Hajioff

Sabrina Ramkellawan

This week, we’re joined by Jaspreet Grewal &amp; Sabrina Ramkellawan, founders of Knowde Group - Canadian contract research organisation and hybrid consultancy specialising in plant-based therapeutics and psychedelics.In this episode, we explore the complexities of clinical trials within the cannabis industry, including barriers to entry, the three phases of clinical trials, how to navigate the regulatory landscape, and access to funding.About Jaspreet Grewal  MBA, MSc, CCRPJaspreet Grewal is an accomplished clinician, researcher and venture partner bringing over 15 years of experience to companies focused on the Life Sciences. Throughout her career, she has held various positions with increasing responsibilities in various healthcare roles resulting in a broad skillset and robust healthcare and investment network while working in Canada, the US, the UK, the Cayman Islands, and Bermuda. Jaspreet holds a Master’s in Clinical Vision Sciences from Georgetown University, an Executive Certificate in Public Health from Harvard University and an MBA from the London School of Economics and Political Science.She is considered an expert in Healthcare and Regulatory Strategy and is a passionate advocate for building Alberta’s Life Science ecosystem. She has successfully merged her expertise in innovation, research and finance to become a dynamic leader not only nationally but internationally. Her current roles and affiliations include:Co-Founder &amp; CEO, Knowde Group (Canada, UK and Australia)Founder &amp; CEO, Venn Consulting (Canada)Board Director, BioAlbertaEntrepreneur in Residence, Innovate Calgary (Medical Cannabis)Global Lifesciences Consultant, Calgary Economic DevelopmentExternal Advisor to the Vi Riddell Pain &amp; Rehabilitation Centre, Alberta Children’s HospitalAbout Sabrina RamkellawanSabrina has over 20 years of clinical research experience in pharma, medical devices, natural health products and plant-based therapeutics including cannabinoids. She has held positions at or advised some top pharmaceutical, cannabis, psychedelic, and research companies. Sabrina has conducted and supported 11 cannabis research studies to date. She has previous experience leading operations at large scale global Contract Research Organisations including INC Research (now Syneos Health) as well as building successful speciality clinics. Sabrina is also passionate about education and has helped to build and currently teaches the first Certified Cannabis Educator Program at Michener Institute of Education at UHN. She has been and continues to be a speaker in the area of research and plant-based medicine. Prior to her role at Knowde Group, she was the VP of Clinical Affairs at TerrAscend Canada which is a licensed producer. In her role as Chief Operating Officer at Knowde Group, she is focused on all aspects of conducting research specialising in plant-based therapeutics and psychedelics. ResourcesJoin Sabrina on LinkedIn: https://www.linkedin.com/in/sabrinaramkellawan/?originalSubdomain=caJoin Jaspreet on LinkedIn: https://www.linkedin.com/in/jkgrewal/Follow Knowde Group on Twitter: https://twitter.com/knowdegroupKnowde Group’s Website: https://www.knowdegroup.com/

This week, we’re joined by Jaspreet Grewal &amp; Sabrina Ramkellawan, founders of Knowde Group - Canadian contract research organisation and hybrid consultancy specialising in plant-based therapeutics and psychedelics. In this episode, we explore the complexities of clinical trials within the cannabis industry, including barriers to entry, the three phases of clinical trials, how to navigate the regulatory landscape, and access to funding. About Jaspreet Grewal  MBA, MSc, CCRPJaspreet Grewal is an accomplished clinician, researcher and venture partner bringing over 15 years of experience to companies focused on the Life Sciences. Throughout her career, she has held various positions with increasing responsibilities in various healthcare roles resulting in a broad skillset and robust healthcare and investment network while working in Canada, the US, the UK, the Cayman Islands, and Bermuda. Jaspreet holds a Master’s in Clinical Vision Sciences from Georgetown University, an Executive Certificate in Public Health from Harvard University and an MBA from the London School of Economics and Political Science. She is considered an expert in Healthcare and Regulatory Strategy and is a passionate advocate for building Alberta’s Life Science ecosystem. She has successfully merged her expertise in innovation, research and finance to become a dynamic leader not only nationally but internationally. Her current roles and affiliations include:<ul><li>Co-Founder &amp; CEO, Knowde Group (Canada, UK and Australia)</li><li>Founder &amp; CEO, Venn Consulting (Canada)</li><li>Board Director, BioAlberta</li><li>Entrepreneur in Residence, Innovate Calgary (Medical Cannabis)</li><li>Global Lifesciences Consultant, Calgary Economic Development</li><li>External Advisor to the Vi Riddell Pain &amp; Rehabilitation Centre, Alberta Children’s Hospital</li></ul>About Sabrina Ramkellawan Sabrina has over 20 years of clinical research experience in pharma, medical devices, natural health products and plant-based therapeutics including cannabinoids. She has held positions at or advised some top pharmaceutical, cannabis, psychedelic, and research companies. Sabrina has conducted and supported 11 cannabis research studies to date. She has previous experience leading operations at large scale global Contract Research Organisations including INC Research (now Syneos Health) as well as building successful speciality clinics. Sabrina is also passionate about education and has helped to build and currently teaches the first Certified Cannabis Educator Program at Michener Institute of Education at UHN. She has been and continues to be a speaker in the area of research and plant-based medicine. Prior to her role at Knowde Group, she was the VP of Clinical Affairs at TerrAscend Canada which is a licensed producer. In her role as Chief Operating Officer at Knowde Group, she is focused on all aspects of conducting research specialising in plant-based therapeutics and psychedelics.  ResourcesJoin Sabrina on LinkedIn: <a href="https://www.linkedin.com/in/sabrinaramkellawan/?originalSubdomain=ca" rel="nofollow" target="_blank">https://www.linkedin.com/in/sabrinaramkellawan/?originalSubdomain=ca</a>Join Jaspreet on LinkedIn: <a href="https://www.linkedin.com/in/jkgrewal/" rel="nofollow" target="_blank">https://www.linkedin.com/in/jkgrewal/</a>Follow Knowde Group on Twitter: <a href="https://twitter.com/knowdegroup" rel="nofollow" target="_blank">https://twitter.com/knowdegroup</a>Knowde Group’s Website: <a href="https://www.knowdegroup.com/" rel="nofollow" target="_blank">https://www.knowdegroup.com/</a>

EPISODE #130 The Future of Clinical Trials in Cannabis with Jaspreet Grewal & Sabrina Ramkellawan, Founders of Knowde Group